Larazotide and Tight Junctions: The Barrier Peptide in KLOW
Larazotide is the least familiar name in the KLOW blend, and the one that most sets KLOW apart from GLOW. It is studied for its effects on tight junctions, the seals between epithelial cells that control what passes through a tissue barrier such as the gut lining. Here is what that means and why it matters in multi-peptide research.
What tight junctions are
Epithelial cells line the gut, skin and other surfaces. Where neighboring cells meet, protein complexes called tight junctions (built from claudins, occludin and zonula occludens proteins) seal the gap. They decide what can pass between cells, the paracellular route. When tight junctions loosen, the barrier becomes more permeable, which is studied in the context of inflammation and intestinal disorders.
The zonulin pathway
Zonulin is a protein identified as a regulator that loosens intestinal tight junctions. Its discovery grew out of research on a bacterial toxin, zonula occludens toxin, that opens tight junctions. Understanding this pathway gave researchers a target for studying how barrier permeability is controlled.
What larazotide is
Larazotide is a synthetic eight-amino-acid peptide (Gly-Gly-Val-Leu-Val-Gln-Pro-Gly) designed to oppose the zonulin pathway and help keep tight junctions closed. It has been studied in cell models of epithelial permeability and has also been evaluated in clinical research on intestinal barrier function, which makes it one of the better-characterized barrier peptides.
What researchers study it for
- Tight-junction assembly and disassembly in epithelial cell layers
- Barrier permeability, measured by trans-epithelial electrical resistance (TEER) or tracer molecules
- How barrier integrity interacts with inflammatory signaling
Why it’s in KLOW
Barrier integrity, inflammation and tissue repair are linked: a leaky barrier lets in triggers of inflammation, and inflammation further loosens the barrier. KLOW combines larazotide (barrier) with KPV (anti-inflammatory signaling) and the repair peptides GHK-Cu, BPC-157 and, in the full blend, TB-500, so all three sides of that loop can be studied together. See GLOW vs KLOW and KPV and other immune peptides.
Larazotide is currently available as part of KLOW and KLOW70, not as a single compound. To separate its contribution, compare KLOW with the GLOW blend or with the individual repair peptides. Our blends vs single peptides guide explains how.
Testing
Every blend lot we sell is tested by Bioviridian Labs (ISO/IEC 17025, Texas) for HPLC purity, mass-spectrometry identity, endotoxin and heavy metals. See the COA Library.
For laboratory research use only. Not for human or veterinary use. This article is for educational purposes and does not provide medical advice.